SEARCH RESULTS

3963 RESULTS

Proteomics Uncovers Potential Markers, Subtypes of Alzheimer’s

CONFERENCE COVERAGE 2019-08-22 Conference Coverage In the last three decades, scientists have made strides in using biomarkers to diagnose Alzheimer’s disease and track its progression. Along with cerebrospinal fluid Aβ, tau, and phospho-tau, a handful of new markers, such as neurofila

Synaptic Proteins in CSF: New Markers of Cognitive Decline?

CONFERENCE COVERAGE 2019-08-22 Conference Coverage Plasma tests for Aβ and phospho-tau may have stolen the show at this year’s Alzheimer’s Association International Conference, held July 14-18 in Los Angeles, but proteomic and synaptic markers were not that far behind. A neural pentrax

PSEN1 N39Y

MUTATIONS PSEN1 73637532 GRCh37/hg19 A T Exon 4 Point, Missense Coding Unknown. Multiple in silico algorithms yielded conflicting results. Unknown N39Y Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This mutation was identified in a genetic screen

Current Filters

  • Date Range : Aug 2019 to Nov 2019 x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE